Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;6(5):191-194.
doi: 10.4088/pcc.v06n0502.

Neuroleptic Malignant Syndrome: A Primary Care Perspective

Sanjay Gupta  1 , Nikhil D Nihalani
Affiliations

Neuroleptic Malignant Syndrome: A Primary Care Perspective

Sanjay Gupta et al. Prim Care Companion J Clin Psychiatry. 2004.

Abstract

In recent years, there has been an increased use of neuroleptic agents in the primary care setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy that can be missed if not suspected. This manuscript reviews the diagnosis and management of NMS in the primary care setting. There is a lack of prospective data, and most of the information is obtained from case series. Physicians need to have a high index of suspicion with regard to excluding NMS in patients taking neuroleptics and presenting with hyperthermia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Delay J, Pichot P, and Lemperiere T. et al. Un neuroleptique majeur non phenothiazine et non reserpine, l'haloperidol, dans le traitement des psychoses [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses.]. Ann Med Psychol (Paris). 1960 118:145–152. - PubMed
    1. Ananth J, Parameswaran S, and Gunatilake S. et al. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004 65:464–470. - PubMed
    1. Pelonero AL, Levenson JL, Pandurangi AK.. Neuroleptic malignant syndrome: a review. Psychiatr Serv. 1998;49:1163–1172.1075-2730(1998)049<1163:NMSAR>2.0.CO;2 - PubMed
    1. Gelenberg AJ, Bellinghausen B, and Wojick JD. et al. A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. Am J Psychiatry. 1998 145:517–518. - PubMed
    1. Keck PE Jr, Sebastianelli J, and Pope HG Jr. et al. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. J Clin Psychiatry. 1989 50:352–355. - PubMed